Discrimination of Candida albicans from Candida dubliniensis by Use of the BioFire FilmArray Blood Culture Identification Panel

Affiliations

¹ Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA Nebraska Public Health Laboratory, Omaha, Nebraska, USA.
² King Fahad Specialist Hospital, Dammam, Saudi Arabia.
³ Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA Nebraska Public Health Laboratory, Omaha, Nebraska, USA piwen@unmc.edu.

Timothy R Southern et al. J Clin Microbiol. 2015 Jun.

. 2015 Jun;53(6):1999-2000.

doi: 10.1128/JCM.00299-15. Epub 2015 Apr 15.

¹ Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA Nebraska Public Health Laboratory, Omaha, Nebraska, USA.
² King Fahad Specialist Hospital, Dammam, Saudi Arabia.
³ Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA Nebraska Public Health Laboratory, Omaha, Nebraska, USA piwen@unmc.edu.

No abstract available

References

1. Delaloye J, Calandra T. 2014. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence 5:161–169. doi:10.4161/viru.26187. - DOI - PMC - PubMed
1. Kollef M, Micek S, Hampton N, Doherty J, Kumar A. 2012. Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 54:1739–1746. doi:10.1093/cid/cis305. - DOI - PubMed
1. Falagas M, Roussos N, Vardakas K. 2010. Relative frequency of C. albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis 14:e954–e966. doi:10.1016/j.ijid.2010.04.006. - DOI - PubMed
1. Sullivan D, Westerneng T, Haynes K, Bennett D, Coleman D. 1995. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141:1507–1521. doi:10.1099/13500872-141-7-1507. - DOI - PubMed
1. Pfaller M, Woosley L, Messer S, Jones R, Castanheira M. 2012. Significance of molecular identification and antifungal susceptibility of clinically significant yeasts and moulds in a global antifungal surveillance programme. Mycopathologia 174:259–271. doi:10.1007/s11046-012-9551-x. - DOI - PubMed